Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Cancer Lett ; 356(2 Pt B): 404-9, 2015 Jan 28.
Article in English | MEDLINE | ID: mdl-25304377

ABSTRACT

Intraductal papillary mucinous neoplasm (IPMN) is a precursor cystic lesion to pancreatic cancer. With the goal of classifying IPMN cases by risk of progression to pancreatic cancer, we undertook an exploratory next generation sequencing (NGS) based profiling study of miRNAs (miRNome) in the cyst fluids from low grade-benign and high grade-invasive pancreatic cystic lesions. Thirteen miRNAs (miR-138, miR-195, miR-204, miR-216a, miR-217, miR-218, miR-802, miR-155, miR-214, miR-26a, miR-30b, miR-31, and miR-125) were enriched and two miRNAs (miR-451a and miR-4284) were depleted in the cyst fluids derived from invasive carcinomas. Quantitative real-time polymerase chain reaction analysis confirmed that the relative abundance of tumor suppressor miR-216a and miR-217 varied significantly in these cyst fluid samples. Ingenuity Pathway Analysis (IPA) analysis indicated that the genes targeted by the differentially enriched cyst fluid miRNAs are involved in five canonical signaling pathways, including molecular mechanisms of cancer and signaling pathways implicated in colorectal, ovarian and prostate cancers. Our findings make a compelling case for undertaking in-depth analyses of cyst fluid miRNomes for developing informative early detection biomarkers of pancreatic cancer developing from pancreatic cystic lesions.


Subject(s)
Biomarkers, Tumor/genetics , Cyst Fluid/metabolism , High-Throughput Nucleotide Sequencing , MicroRNAs/genetics , Pancreatic Cyst/genetics , Pancreatic Neoplasms/genetics , Adenocarcinoma, Mucinous/genetics , Adenocarcinoma, Mucinous/pathology , Carcinoma, Pancreatic Ductal/genetics , Carcinoma, Pancreatic Ductal/pathology , Gene Regulatory Networks , Humans , Neoplasm Grading , Neoplasm Invasiveness , Pancreatic Cyst/pathology , Pancreatic Neoplasms/pathology , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction
2.
Am J Physiol Gastrointest Liver Physiol ; 304(11): G1002-12, 2013 Jun 01.
Article in English | MEDLINE | ID: mdl-23558009

ABSTRACT

Chronic pancreatitis (CP) is a devastating disease characterized by persistent and uncontrolled abdominal pain. Our lack of understanding is partially due to the lack of experimental models that mimic the human disease and also to the lack of validated behavioral measures of visceral pain. The ligand-gated cation channel transient receptor potential ankyrin 1 (TRPA1) mediates inflammation and pain in early experimental pancreatitis. It is unknown if TRPA1 causes fibrosis and sustained pancreatic pain. We induced CP by injecting the chemical agent trinitrobenzene sulfonic acid (TNBS), which causes severe acute pancreatitis, into the pancreatic duct of C57BL/6 trpa1(+/+) and trpa1(-/-) mice. Chronic inflammatory changes and pain behaviors were assessed after 2-3 wk. TNBS injection caused marked pancreatic fibrosis with increased collagen-staining intensity, atrophy, fatty replacement, monocyte infiltration, and pancreatic stellate cell activation, and these changes were reflected by increased histological damage scores. TNBS-injected animals showed mechanical hypersensitivity during von Frey filament probing of the abdomen, decreased daily voluntary wheel-running activity, and increased immobility scores during open-field testing. Pancreatic TNBS also reduced the threshold to hindpaw withdrawal to von Frey filament probing, suggesting central sensitization. Inflammatory changes and pain indexes were significantly reduced in trpa1(-/-) mice. In conclusion, we have characterized in mice a model of CP that resembles the human condition, with marked histological changes and behavioral measures of pain. We have demonstrated, using novel and objective pain measurements, that TRPA1 mediates inflammation and visceral hypersensitivity in CP and could be a therapeutic target for the treatment of sustained inflammatory abdominal pain.


Subject(s)
Pancreatitis, Chronic/genetics , Transient Receptor Potential Channels/genetics , Animals , Central Nervous System Sensitization/genetics , Disease Models, Animal , Fibrosis/genetics , Inflammation/genetics , Injury Severity Score , Locomotion/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Pancreatitis, Chronic/chemically induced , Pancreatitis, Chronic/pathology , Pancreatitis, Chronic/physiopathology , TRPA1 Cation Channel , Trinitrobenzenesulfonic Acid/pharmacology , Visceral Pain/genetics
3.
Surg Obes Relat Dis ; 9(1): 108-12, 2013.
Article in English | MEDLINE | ID: mdl-22093377

ABSTRACT

BACKGROUND: Although women disproportionately undergo bariatric surgery, the rodent models investigating the mechanisms of bariatric surgery have been limited to males. Female rodent models can also potentially allow us to understand the effects of surgical intervention on future generations of offspring. Sleeve gastrectomy is an attractive weight loss procedure for reproductive-age female patients because it avoids the malabsorption associated with intestinal bypass. We sought to evaluate the effect of sleeve gastrectomy on young female rats with diet-induced obesity at the University of California, Los Angeles, David Geffen School of Medicine. METHODS: Sprague-Dawley female rats were fed a 60% high-fat diet. At 12 weeks of age, the rats underwent either sleeve gastrectomy or sham surgery. The rats were killed 4 weeks after surgery. A chemistry panel was performed, and the serum adipokines and gut hormones were assayed. The homeostasis model assessment score was calculated. The liver histologic findings were graded for steatosis. The 2-sample t test was used to compare the results between the 2 groups. RESULTS: Sleeve gastrectomy was associated with significant weight loss (5% ± 6% versus -4% ± 6%; P < .001), lower leptin levels (1.3 ± 1.2 versus 3.5 ± 2.3 ng/mL; P < .01), and higher adiponectin levels (.43 ± .19 versus .17 ± .14 ng/mL; P < .004) compared with the sham-operated rats. No significant differences were found in the fasting ghrelin levels. Furthermore, we did not observe evidence of insulin resistance or steatohepatitis after 11 weeks of high-fat diet. Despite these limitations, additional gender-specific studies are warranted given that most bariatric surgeries are performed in women. CONCLUSION: Sleeve gastrectomy appears to result in weight loss and improvements in adiponectin and leptin by way of mechanisms independent of ghrelin levels in a female model of diet-induced obesity.


Subject(s)
Diet, High-Fat , Gastrectomy/methods , Obesity/metabolism , Adipokines/metabolism , Adiponectin/metabolism , Animals , Biomarkers/metabolism , Blood Glucose/metabolism , Female , Gastrointestinal Hormones/metabolism , Leptin/metabolism , Models, Animal , Obesity/etiology , Obesity/surgery , Random Allocation , Rats , Rats, Sprague-Dawley , Weight Loss
5.
J Pediatr Surg ; 46(12): 2321-6, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22152874

ABSTRACT

PURPOSE: Prior studies demonstrated the feasibility of lengthening intestinal segments with mechanical force, but no previous studies have restored the lengthened segment back into intestinal continuity. METHODS: A 1-cm segment of isolated rat jejunum was lengthened using a Nitinol spring. After lengthening, this segment was restored into intestinal continuity via a transection of the intact small intestine. Rats were euthanized 2 weeks later to retrieve the restored intestinal segment for histologic and enzymatic analyses. RESULTS: The isolated jejunal segments were initially lengthened to 3.3 ± 0.9 cm. After the lengthened segments were restored into intestinal continuity for 2 weeks, the final length of the restored segment was 1.9 ± 0.7 cm. All rats continued to gain weight, and the intestine proximal to the restored jejunal segment remained normal 2 weeks later. The restored jejunal segment had an increase in crypt depth and no difference in villus height compared with normal jejunum. Sucrase activity in the restored segment was not different from that in normal jejunum. CONCLUSION: Mechanically lengthened jejunum can be restored into intestinal continuity and appears to have normal function. This further demonstrates the feasibility of mechanical enterogenesis as a potential therapy for short bowel syndrome.


Subject(s)
Jejunum/surgery , Tissue Expansion Devices , Tissue Expansion/methods , Alloys , Anastomosis, Surgical/methods , Animals , Capsules , Cellulose/analogs & derivatives , Coated Materials, Biocompatible , Disease Models, Animal , Equipment Design , Female , Implants, Experimental , Intestinal Mucosa/enzymology , Intestinal Mucosa/ultrastructure , Jejunum/enzymology , Jejunum/ultrastructure , Microvilli/ultrastructure , Organ Size , Polyethylene , Rats , Rats, Sprague-Dawley , Short Bowel Syndrome/surgery , Stress, Mechanical , Sucrase/analysis , Tissue Expansion/instrumentation , Weight Gain
6.
Curr Opin Pediatr ; 23(5): 552-6, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21804384

ABSTRACT

PURPOSE OF REVIEW: The review summarizes the recent studies of bariatric surgery outcomes in adolescents. RECENT FINDINGS: Randomized prospective studies demonstrate superior weight loss, resolution of comorbidities, and improvement in quality of life in morbidly obese adolescents undergoing bariatric surgery vs. lifestyle changes alone. The enthusiasm for laparoscopic adjustable banding (LAGB) has been tempered by high reoperation rates. Laparoscopic sleeve gastrectomy (LSG) is a promising procedure for adolescents because it avoids intestinal bypass and implantation of a foreign body; recent data from adult series demonstrate mid-term results comparable with laparoscopic roux-en-y gastric bypass (LRYGB) with an improved safety profile. SUMMARY: Bariatric surgery is superior to lifestyle changes alone in treating adolescent morbid obesity. LRYGB remains the gold-standard operation for both adolescents and adults. Although LAGB and LSG are appealing because they avoid intestinal bypass, long-term studies are needed to fully evaluate their efficacy and safety in the adolescent population.


Subject(s)
Bariatric Surgery , Obesity, Morbid/surgery , Adolescent , Bariatric Surgery/methods , Comorbidity , Diabetes Mellitus, Type 2/complications , Gastrectomy , Humans , Laparoscopy , Metabolic Syndrome/complications , Obesity, Morbid/complications , Sleep Apnea, Obstructive/etiology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...